The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Tuesday: ** Eli Lilly and Co said on Tuesday it would purchase Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash to strengthen and diversify its Elanco unit.** Activist investor William Ackman teamed up with Canadian drugmaker Valeant Pharmaceuticals International Inc to make a joint run at buying wrinkle-treatment maker Allergan Inc , according to security filings on Monday.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 6.03% or $8.08/share to $142.00. In the past year, the shares have traded as low as $81.33 and as high as $142.00. On average, 3082430 shares of AGN exchange hands on a given day and today's volume is recorded at 10559753.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.24% or $3.96/share to $126.01. In the past year, the shares have traded as low as $71.99 and as high as $153.10. On average, 1992590 shares of VRX exchange hands on a given day and today's volume is recorded at 2789973.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.21% or $4.31/share to $138.76. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 372348 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 318584.
Source
